Literature DB >> 2468939

Differential effects of verapamil and flunarizine on epinephrine-induced vasoconstriction and on spontaneous vasomotion of arterioles in skeletal muscle in the rat in vivo.

F De Clerck1, W Loots, J Voeten, P A Janssen.   

Abstract

The effects of verapamil and of flunarizine on the epinephrine-induced vasoconstriction and on the spontaneous vasomotion of third-to-fourth-order arterioles (range 9-25 microns diameter) in the rat cremaster muscle were compared, using quantitative intravital microscopy. Verapamil as well as flunarizine [0.5 mg/kg intravenously (i.v.) in 10 s; 10-50 min postmedication] similarly reduced the submaximal arteriolar vasoconstriction induced by topically applied epinephrine (maximal concentrations 1 x 10(-7) and 1 x 10(-6) M), illustrating their inhibitory action against stimulated Ca2+ influx into vascular smooth muscle cells at the doses examined. Verapamil increased the basal arteriolar diameter (+54.6%), and reduced the frequency (-82.1%) and velocity (-65.8%) of the spontaneously cyclic changes in the diameter of arterioles, typical for the autoregulation of microcirculatory blood flow. In contrast, flunarizine slightly increased basal arteriolar diameter (+16.5%) but did not modify the pattern of spontaneous arteriolar vasomotion. The effect of verapamil and inactivity of flunarizine on the spontaneous arteriolar vasomotion may result from an interference by the former drug with the myogenic activity of vascular smooth muscle cells, caused by Ca2+ translocations in physiologic conditions and the lack of such an interference by the latter compound. These observations performed on the same blood vessels corroborate the differentiation between Ca2+ slow channel blockers (verapamil) and Ca2+ overload blockers (flunarizine) in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468939

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations.

Authors:  N H Buus; E VanBavel; M J Mulvany
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

Review 2.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.